Safety of denosumab versus zoledronic acid in the older adults with osteoporosis: a meta-analysis of cohort studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of denosumab versus zoledronic acid in the older adults with osteoporosis: a meta-analysis of cohort studies

Published:2022-06-17 Issue:1 Volume:17 Page:
ISSN:1862-3522
Container-title:Archives of Osteoporosis
language:en
Short-container-title:Arch Osteoporos

Author:

Li Weiwei,Ning Zeqiong,Yang Zhifu,Fan Tingting,Yao Minna,Zhang Wei,Wang Mingming,Wen Aidong,Wang Jingwen

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11657-022-01129-2.pdf

Reference34 articles.

1. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377(9773):1276–1287

2. Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L, Lin H, Jin X, Dong Z, Ren Z, Hou Z, Zhang Y, Zhong J, Cai S, Liu Y, Meng R, Deng Y, Ding X, Ma J, Xie Z, Shen L, Wu W, Zhang M, Ying Q, Zeng Y, Dong J, Cummings SR, Li Z, Xia W (2021) Prevalence of osteoporosis and fracture in China: the China Osteoporosis Prevalence Study. JAMA Netw Open 4(8):e2121106

3. Coughlan T, Dockery F (2014) Osteoporosis and fracture risk in older people. Clin Med (Lond) 14(2):187–191

4. Zhang C, Feng J, Wang S, Gao P, Xu L, Zhu J, Jia J, Liu L, Liu G, Wang J, Zhan S, Song C (2020) Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLoS Med 17(8):e1003180

5. Hou XL, Liu JY, Fan XH, Zhang N, Cao GL, Guo ZB, Zhang YY, Yu YH, Tian YQ, Sun XX, Tian FM (2022) Secular trends of incidence and hospitalization cost of hip fracture in Tangshan. China Osteoporos Int 33(1):89–96

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond;Balneo and PRM Research Journal;2024-06-21

2. Difficulties in decision making on a long standing, complicated case of osteoporosis – a real challenge for functional rehabilitation;Balneo and PRM Research Journal;2023-12-20

3. Side effects of drugs for metabolic bone disease;Side Effects of Drugs Annual;2023

4. Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database;Journal of Pharmacy Technology;2022-12-28

5. Denosumab versus zoledronic acid in elderly patients after hip fracture;Journal of Orthopaedic Surgery;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3